EPM2A and prostate adenocarcinoma: Based on TCGA-PRAD cohort, we observed higher EPM2A PCA had a significantly longer OS than low EPM2A PCA, which was validated in univariate Cox regression analysis, and further multivariate Cox regression analysis manifested the independent role of EPM2A to prognosis.